Yahoo Web Search

Search results

    • Image courtesy of thno.org

      thno.org

      Trastuzumab

      • Trastuzumab is a targeted therapy known as a monoclonal antibody, a modified version of an immune system protein, that can target proteins on HER2-positive breast cancer cells and stop them from growing. Herceptin is the brand name for trastuzumab, the most common medicine used to treat HER2-positive breast cancer.
      www.lbbc.org › about-breast-cancer › treatments
  1. People also ask

  2. May 20, 2024 · In 2020, ASCO published a guideline on the selection of optimal adjuvant chemotherapy and targeted therapy for breast cancer. 1 This is a rapid recommendation update of that guideline that addresses, in turn, the adjuvant use of the cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors abemaciclib and ribociclib in patients with stage II and III ...

  3. May 16, 2024 · Treatment for early breast cancer (including invasive ductal carcinoma and invasive lobular carcinoma) includes some combination of: Surgery. Radiation therapy. Chemotherapy. Hormone therapy. HER2-targeted therapy. CDK4/6 inhibitor therapy. Immunotherapy. PARP inhibitor therapy. Getting a second opinion.

  4. 3 days ago · Breast cancer targeted therapy is commonly paired with other treatments, such as chemotherapy, to help control cancer that has spread or to prevent breast cancer recurrence. Beyond HER2-positive breast cancers , targeted therapies may also be used to help treat:

  5. May 16, 2024 · Your treatment plan is guided by many factors, including: The biology of the tumor, including biomarkers (such as hormone receptor status and HER2 status) Where the cancer has spread. Your symptoms. Your past breast cancer treatments. Whether you have a BRCA1 or BRCA2 inherited gene mutation.

  6. May 28, 2024 · Trastuzumab is a standard treatment for people diagnosed with early- stage or metastatic HER2-positive breast cancer. In early-stage breast cancer, trastuzumab works to reduce the risk of the cancer coming back. In metastatic breast cancer, it works to slow the cancer’s growth.

  7. 6 days ago · Targeted treatments are medicines that attack proteins on breast cancer cells that help them grow and spread. [ 4 ] Two types of targeted therapies are used for metastatic TNBC:

  8. 4 days ago · When we use chemotherapy plus HER2-targeted drugs in truly HER2-positive breast cancer, we see incredible efficacy of those regimens. And so, we didn't see the correlation with the outcomes that we expected because in fact, what our results suggested is that the treatment worked really well for everyone. And that's congruent with what we've now ...

  1. People also search for